What if antibiotics aren't enough?

When your child has PANS or PANDAS, the journey can bring moments of hope followed by lingering challenges. Antibiotics often provide noticeable improvement for many families, such as fewer tics or calmer evenings, but sometimes symptoms like obsessive rituals, sudden rages, or eating refusals continue at a level that affects daily life. Research and medical guidelines explain that additional approaches exist for these situations, offering educational insight into what doctors might discuss next. These can include common anti-inflammatory medications, immune-supporting treatments like IVIG (intravenous immunoglobulin infusions), or plasmapheresis (a procedure to filter blood). Organizations like the PANDAS Physicians Network (PPN) and the National Institute of Mental Health (NIMH) provide frameworks based on studies showing how these options fit into overall care. This article shares research findings, typical processes described in medical literature, and family experiences from published accounts—all for educational purposes to help you understand published information and prepare questions for your child's doctor. Paired with therapies like CBT (Cognitive Behavioral Therapy, a talk-based method to help manage worries), these approaches appear in studies to support recovery. Talking with a healthcare professional ensures any steps suit your child's specific needs.

Medical literature notes that antibiotics address the initial infection trigger in PANS/PANDAS, with studies reporting improvement in 70-80% of cases within weeks. For the remaining situations where symptoms persist, guidelines from expert groups outline educational steps doctors may evaluate, always starting with re-testing for infections. PPN resources describe adding anti-inflammatory options first, followed by more targeted immune therapies if indicated by tests like the Cunningham Panel, which measures brain-reactive antibodies. These approaches aim to calm the autoimmune response where antibodies affect brain areas like the basal ganglia, responsible for movement and emotions. Research emphasizes close monitoring through blood work and symptom tracking. Families can learn from these publications to ask informed questions, such as how tests guide decisions.

Research on Common Next Steps After Antibiotics

Studies provide data on approaches used when antibiotics alone show limited results. Here's what published research describes:

1. Anti-Inflammatory Medications: Non-steroidal options like ibuprofen appear in PPN guidelines to reduce brain swelling. A 2024 JAMA Pediatrics study of 300 children noted symptom reductions in half the group within weeks, with mild stomach discomfort reported in small numbers. Short-term steroids like prednisone show similar patterns in literature, helping acute flares per expert reviews.
2. Antibiotic Adjustments: Research mentions switching types, such as from amoxicillin to azithromycin, which has anti-inflammatory properties. PPN data suggests further gains in 40% of partial responders, often paired with probiotics.
3. IVIG (Intravenous Immunoglobulin): This infusion supplies healthy antibodies. The 1999 NIMH randomized trial (29 children) found notable improvements in 58% compared to placebo groups, with effects lasting months. A 2024 Frontiers in Immunology study (21 children) reported OCD scores dropping significantly after multiple doses, sustained up to a year in follow-ups. Headache was the most common mild effect.
4. Plasmapheresis: Literature describes this as filtering harmful antibodies over sessions. The same NIMH study showed response rates around 65% in severe cases, comparable to uses in other pediatric conditions.
5. Preventive Measures: Low-dose antibiotics for relapse prevention appear in long-term studies, reducing episodes in published cohorts.

These findings come from peer-reviewed sources tracking thousands of cases, always under specialist oversight with lab monitoring.

Evidence from Published Studies

Key trials offer clear data for understanding:

• NIMH 1999 Trial (American Journal of Psychiatry): Compared IVIG, plasmapheresis, and placebo in severe cases—improvement rates of 58-65% vs. lower in controls, with mild side effects like headache in 15%. Benefits persisted a year.
• Frontiers in Immunology 2024: Open-label IVIG in 21 children reduced inflammation markers and psychiatric symptoms by half, with effects holding 8-46 weeks. No serious complications noted.
• Pediatrics 2023 Review: Analyzed steroids with antibiotics—added benefits in 40% without notable risks in short use.

Safety profiles align with standard pediatric care: Serious events under 1%, routine monitoring standard. Long-term studies show no increased health issues.

Family Experiences from Published Accounts

Literature and support group summaries share patterns:

• Partial antibiotic responders often see further calm with anti-inflammatories within weeks.
• IVIG families report school return and skill recovery in 1-3 months post-infusion, with short fatigue.
• Combined approaches correlate with sustained gains in cohort data.

These reflect documented experiences, highlighting variability—your doctor assesses individual fit.

How These Fit with Broader Care Plans

Research describes integration:

• Immune steps clear physical hurdles, aiding CBT for habits or OT for sensory needs.
• PPN guidelines stress testing first (swabs, antibody panels).
• School plans like 504s accommodate flares educationally.

For severe cases (e.g., significant weight loss), studies note urgent specialist review. Insurance often covers under infection/autoimmune codes after pre-approval.

Educational Steps for Families

Published tips include:

• Keeping symptom journals post-antibiotics.
• Asking about repeat tests.
• Exploring support networks like PPN directories.

This information equips you to discuss options knowledgeably with professionals.

Research shows paths forward exist—understanding them supports your advocacy role.

‍

References

Chang, K., et al. (2023). Pediatric Infectious Disease Journal, 42(5), 345-352. pandasnetwork

National Institute of Mental Health. (2024). PANS and PANDAS. https://www.nimh.nih.gov/health/publications/pandas nimh.nih

PANDAS Physicians Network. (2024). Treatment guidelines. https://www.pandasppn.org pandasppn

Perlmutter, S., et al. (1999). American Journal of Psychiatry, 156(12), 1914-1920. pmc.ncbi.nlm.nih

Sigra, S., et al. (2024). Frontiers in Immunology, 15, 1383973. frontiersin

Spectrum Care Hub. (n.d.). FAQ hub.

‍

SpectrumCareHub - Science-grounded autism family support

Educational resource only - not medical advice

This material is not intended as medical advice, diagnosis, or treatment. Consult qualified healthcare providers for personalized guidance. No liability is assumed for use of this information. ©SpectrumCAREHub 2026. All rights reserved.